Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory-Reference-Cited by-同舟云学术

Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory

Published:2013-02-04 Issue:3 Volume:19 Page:e133-e138
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Cauchie M.¹,Toelen J.¹,Peerlinck K.¹,Jacquemin M.¹

Affiliation:

1. Center for Molecular and Vascular Biology; University of Leuven; Leuven; Belgium

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12093/fullpdf

Reference12 articles.

1. Plasma FVIII levels measured after infusion of recombinant FVIII (rFVIII) vary significantly with different assay methods (will the real FVIII please stand up!);Lusher;Blood,1995

2. In vivo recovery with products of very high purity-assay discrepancies;Lusher;Haemophilia,1998

3. Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay;Lee;Thromb Haemost,1999

4. A survey of one-stage and chromogenic potencies in therapeutic factor VIII concentrates;Hubbard;Br J Haematol,2002

5. ReFacto field study participants. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays;Ingerslev;J Thromb Haemost,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT);European Journal of Haematology;2020-05-27

2. Factor VIII assays in treated hemophilia A patients;Hématologie;2019-12

3. Factor VIII assays in treated hemophilia A patients;Annales de Biologie Clinique;2019-02

4. Clotting and chromogenic factor VIII assay variability in post‐infusion and spiked samples containing full‐length recombinant FVIII or recombinant factor VIII Fc fusion protein ( rFVIIIF c);International Journal of Laboratory Hematology;2018-12-17

5. New challenges and best practices for the laboratory monitoring of factor VIII and factor IX replacement;International Journal of Laboratory Hematology;2018-05